American Society for Men's Health (ASMH)

The American Society for Men’s Health (ASMH) was founded in 2012 and is dedicated to the rapidly growing field of men’s health. The ASMH comprehensively brings together multiple disciplines such as urology, family medicine, cardiology, endocrinology, oncology, gerontology, psychiatry, psychology, sexual and reproductive medicine, public health and others.

Target Audience

The primary audience for this meeting will be urologists and primary care clinicians, however the content being presented would be of interest to many specialties including cardiology, endocrinology, oncology, gerontology, psychiatry, psychology, sexual and reproductive medicine and public health.

Learning Objectives

After participating in this online activity, participants should be able to:
1. Explain the controversies of prostate cancer PSA screening from both urology and primary care perspectives.
2. Review AUA guideline amendment for castrate resistant prostate cancer.
3. Assess the outcomes and selection of treatment options for prostate cancer.
4. Interpret options for caring for men with side effects from prostate cancer treatment.
5. Review the controversies surrounding the treatment of men with late onset hypogonadism.
6. Examine the relationship between metabolic parameters composing metabolic syndrome and testosterone deficiency.
7. Determine if testosterone repletion reverses metabolic dysfunction (eg insulin resistance).
8. Summarize what the current longitudinal and RCTs suggest regarding the relationship between testosterone use and cardiovascular endpoints: MI and CVA.

Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 Non-Physician Participation
Course opens: 
05/11/2015
Course expires: 
05/11/2016
Rating: 
0

Faculty Disclosures
 
Gerald L. Andriole Jr., MD: Augmenix: Consultant or Advisor,Other; Bayer: Consultant or Advisor; Medivation: Scientific Study or Trial; Traxxsson: Scientific Study or Trial; Genomic Health:Consultant or Advisor
Anthony J. Bella, MD: American Medical Systems: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Abbott: Consultant or Advisor, Meeting Participant or Lecturer
Culley C. Carson III, MD: AMS, Auxillium, Coloplast: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; AMS, Auxillium, GSK, Coloplast, Pfizer: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
E. David Crawford, MD:  NIH: Scientific Study or Trial; University of Colorado Cancer Center: Scientific Study or Trial; Ferring: Consultant or Advisor; Janssen: Consultant or Advisor; Dendreon: Consultant or Advisor; Bayer: Consultant or Advisor, Meeting Participant or Lecturer; MDx: Consultant or Advisor; Genomic Health: Consultant or Advisor
Steven A. Kaplan, MD: Pfizer: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Astellas: Consultant or Advisor, Scientific Study or Trial
Edward Karpman, MD: American Medical Systems: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Endo Pharmaceuticals: Meeting Participant or Lecturer; Auxilium: Meeting Participant or Lecturer; Procept Biorobotics: Consultant or Advisor, Investment Interest; Procept Biorobotics: Consultant or Advisor, Investment Interest
Mohit Khera, MD, MBA, MPH: Allergan: Scientific Study or Trial; Lilly: Meeting Participant or Lecturer; Coloplast: Consultant or Advisor, Meeting Participant or Lecturer; Merck: Consultant or Advisor, Meeting Participant or Lecturer; Endo Pharmaceuticals/American Medical Systems: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Sprout Pharmaceuticals: Investment Interest; Journal of Sexual Medicine: Health Publishing; Sexual Medicine Society of North America: Leadership Position
Kurt A. McCammon, MD: Urology Of Virginia: Leadership Position, Employee; AMS: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Astellas: Scientific Study or Trial; Allergan: Scientific Study or Trial
Kevin T. McVary, MD: Astellas: Scientific Study or Trial; Watson Pharmaceuticals: Consultant or Advisor; Lilly/ICOS: Consultant or Advisor, Scientific Study or Trial, Other; NxThera: Scientific Study or Trial; NIDDK: Scientific Study or Trial; AMS: Scientific Study or Trial
Martin M. Miner, MD: Forest Pharmaceuticals: Scientific Study or Trial
Ajay Nehra, MD: Society of Mens Health: Leadership Position; AUA NEWS: Leadership Position;
Journal of Mens Health: Leadership Position; Sexual Medicine Society of North America: Leadership Position; ICUD: Meeting Participant or Lecturer; Journal of Urology:  Health Publishing
Matthew Nielsen, MD, MS: American College of Physicians High Value Care Task Force: Consultant or Advisor
Claus G. Roehrborn, MD: Glaxo Smith Kline: Consultant or Advisor, Meeting Participant or Lecturer; VA Corporate Studies: Health Publishing, Scientific Study or Trial; Southwest Oncology Group: Scientific Study or Trial; NIDDK: Health Publishing, Scientific Study or Trial; CALGB Clinical Trial Group: Scientific Study or Trial; Lilly Icos: Health Publishing, Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Watson Pharmaceuticals: Consultant or Advisor,Meeting Participant or Lecturer; Protox: Consultant or Advisor, Scientific Study or Trial; Neotract: Consultant or Advisor, Scientific Study or Trial; NERI: Consultant or Advisor, Scientific Study or Trial; Afferent: Consultant or Advisor; Urologix: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; AMS: Scientific Study or Trial
Matt T. Rosenberg, MD: Astellas: Consultant or Advisor, Meeting Participant or Lecturer; Pfizer: Consultant or Advisor, Other: Lilly: Consultant or Advisor, Meeting Participant or Lecturer
Jaspreet S. Sandhu, MD: American Medical Systems: Consultant or Advisor
Allen D. Seftel, MD: J of Urology: Leadership Position; american geriatrics society           : Leadership Position; urology care foundation: Leadership Position; mid -atlantic section of AUA: Leadership Position; AUA NPP committee: Leadership Position; patient pocket, llc: Product Development;   international journal of impotence research: Leadership Position
Thomas J. Walsh, MD, MS: American Medical Systems: Consultant or Advisor, Meeting Participant or Lecturer; Endo Health Solutions: Consultant or Advisor, Meeting Participant or Lecturer
 
Planner Disclosures
Education Council

Christopher Lee Amling, MD: Nothing to disclose
Gopal Badlani, MD: Lithotripsy Group: Piedmont Stone & Physician Discovery: Investment Interest; Society of University Urologist: Leadership Position; NIDDK: Leadership Position; Endourology Society: Other     
Timothy Charles Brand, MD: Nothing to disclose   
Peter Robert Carroll, MD, MPH: NIH: Scientific Study or Trial; Department of Defense: Scientific Study or Trial; Myriad Genetics: Scientific Study or Trial; Genomic Health: Scientific Study or Trial; AUA Update: Leadership Position; Medivation/Astellas: Consultant or Advisor
Sam S. Chang, MD: Astellas: Consultant or Advisor; NIH: Scientific Study or Trial; Cold Genesys, Inc.: Scientific Study or Trial; GLG: Consultant or Advisor; Bayer: Consultant or Advisor; Tolmar: Consultant or Advisor
Pat Fox Fulgham, MD: Urology Clinics of North Texas: Investment Interest
Matthew Thomas Gettman, MD: Nothing to disclose
Inderbir Singh Gill, MD, MCh: Hansen Medical: Investment Interest; EDAP: Consultant or Advisor; Mimic: Consultant or Advisor
Misop Han, MD: Nothing to disclose
David Alan Hatch, MD: Pfizer: Scientific Study or Trial
Christina Hernandez (AUA Staff): Nothing to disclose        
Douglas A. Husmann, MD: Nothing to disclose
Mark L. Jordan, MD, FACS: Nothing to disclose       
Wes Kassouf, MD: Nothing to disclose  
Louis Koncz, PA-C: American Medical Systems: Meeting Participant or Lecturer
Tracey Lynn Krupski, MD: Nothing to disclose
Cheryl Taylore Lee, MD: Endo Pharmaceuticals: Scientific Study or Trial
Thomas Sean Lendvay, MD: Spi Surgical Inc.: Consultant or Advisor, Owner, Product Development; CSATS, Inc.: Consultant or Advisor, Investment Interest, Owner, Product Development
Yair Lotan, MD: Abbott: Scientific Study or Trial; Danone: Consultant or Advisor, Scientific Study or Trial; Cepheid: Scientific Study or Trial; Pacific Edge: Scientific Study or Trial; FKD: Scientific Study or Trial 
Jill A. Macoska, PhD: Nothing to disclose
Elspeth Marguerita McDougall, MD: Nothing to disclose  
Manoj Monga, MD: Fortec: Other; Endourology Society: Leadership Position; Practical Reviews in Urology: Health Publishing
John Patrick Mulhall, MD: Association of Peyronie's Disease Advocates (APDA): Leadership Position; Pfizer: Scientific Study or Trial; Absorption Pharmaceuticals: Consultant or Advisor; AMS: Consultant or Advisor, Scientific Study or Trial; Lilly: Consultant or Advisor; Alliance for Fertility Preservation: Leadership Position; Coloplast: Scientific Study or Trial
Victor William Nitti, MD: Astellas: Health Publishing, Consultant or Advisor, Scientific Study or Trial; Allergan: Health Publishing, Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Coloplast: Health Publishing, Consultant or Advisor, Scientific Study or Trial; Serenity Pharmaceuticals: Consultant or Advisor, Investment Interest; American Medical Systems: Health Publishing, Consultant or Advisor, Scientific Study or Trial; Theracoat: Consultant or Advisor; Pneumoflex: Consultant or Advisor; Pfizer: Consultant or Advisor 
Gail S. Prins, PhD: Nothing to disclose 
Lee Richstone, MD: Nothing to disclose
Marianne D. Sadar, PhD: ESSA Pharma Inc.: Leadership Position, Consultant or Advisor, Investment Interest
Karl-Dietrich Sievert, MD, PhD: AMS: Meeting Participant or Lecturer; Karl Storz: Meeting Participant or Lecturer; Medtronics: Meeting Participant or Lecturer, Scientific Study or Trial; Allergen: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Neotract: Meeting Participant or Lecturer
Joseph A. Smith, Jr., MD: Nothing to disclose
Sheila Stark, PhD (AUA Staff): Nothing to disclose 
Sean Patrick Stroup, MD: Intuitive Surgical: Meeting Participant or Lecturer; NeoTract: Meeting Participant or Lecturer
Chandru P. Sundaram, MD: Journal of Endourology and Videourology: Leadership Position; Sonacare, Inc.: Scientific Study or Trial; OnTarget Inc: Scientific Study or Trial; IAUA: Leadership Position
Edouard John Trabulsi, MD: Nothing to disclose
Paul Jacob Turek, MD: MandalMed: Leadership Position; Medical Board of California: Consultant or Advisor; HealthLoop.com: Consultant or Advisor, Investment Interest; Doximity, Inc.: Consultant or Advisor, Investment Interest; Fertility Planit, Inc.: Consultant or Advisor, Investment Interest; Episona, Inc: Consultant or Advisor; BioQuiddity, Inc.: Consultant or Advisor, Investment Interest; Essential Beginnings, Inc: Leadership Position, Investment Interest, Owner, Product Development
Jennifer Yates, MD: Nothing to disclose

Method of Participation
To claim CME credit/hours of participation for each webcast, the learner must view the webcast, complete the posttest, passing with 80% accuracy and submit the evaluation.
 
Estimated time to complete this activity: 4.25 hours
 
Release Date: June, 2015
Expiration Date: June, 2016
 
Accreditation Statement
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation
The American Urological Association designates this enduring material for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
If you have already received credit for this course by attending it or watching it live you cannot receive additional credit.
 
Evidence Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
 
AUA Disclosure Policy 
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
 
Resolution of Identified Conflict of Interest 
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.
 
Disclaimer
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
 
Reproduction Permission
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
 
AUA Privacy and Confidentiality Policy
www.auanet.org/education/confidentiality-statement.cfm
 
Contact Information
American Urological Association
Office of Education
1000 Corporate Blvd.
Linthicum, MD 21090
Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800
 
CME Information
For all inquiries regarding CME credit email: cme@AUAnet.org

Acknowledgements
The AUA Office of Education would like to thank the companies who support continuing education of physicians. The AUA recognizes the following companies for providing educational grant support:
 
AbbVie
 
AUAER ensures that all educational activities are developed and implemented independent of the control and/or influence of any commercial interests (ACCME: SCS1)

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 Non-Physician Participation

Accreditation Period

Course opens: 
05/11/2015
Course expires: 
05/11/2016
Please login or register to take this course.